[HTML][HTML] HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
Background HIV proteins Nef and Vpu down-modulate various host factors to evade immune
defenses. Indeed, the CD4 receptor is down-regulated by Nef and Vpu, whereas virion …
defenses. Indeed, the CD4 receptor is down-regulated by Nef and Vpu, whereas virion …
HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages
H Lahouassa, ML Blondot… - Proceedings of the …, 2016 - National Acad Sciences
Viruses often interfere with the DNA damage response to better replicate in their hosts. The
human immunodeficiency virus 1 (HIV-1) viral protein R (Vpr) protein has been reported to …
human immunodeficiency virus 1 (HIV-1) viral protein R (Vpr) protein has been reported to …
Characterization of Simian Immunodeficiency Virus SIVSM/Human Immunodeficiency Virus Type 2 Vpx Function in Human Myeloid Cells
Human immunodeficiency virus type 2 (HIV-2)/simian immunodeficiency virus SIVSM Vpx is
incorporated into virion particles and is thus present during the early steps of infection, when …
incorporated into virion particles and is thus present during the early steps of infection, when …
[HTML][HTML] Hijacking of the ubiquitin/proteasome pathway by the HIV auxiliary proteins
T Seissler, R Marquet, JC Paillart - Viruses, 2017 - mdpi.com
The ubiquitin-proteasome system (UPS) ensures regulation of the protein pool in the cell by
ubiquitination of proteins followed by their degradation by the proteasome. It plays a central …
ubiquitination of proteins followed by their degradation by the proteasome. It plays a central …
[HTML][HTML] The ubiquitin-conjugating system: multiple roles in viral replication and infection
A Calistri, D Munegato, I Carli, C Parolin, G Palù - Cells, 2014 - mdpi.com
Through the combined action of ubiquitinating and deubiquitinating enzymes, conjugation of
ubiquitin to a target protein acts as a reversible post-translational modification functionally …
ubiquitin to a target protein acts as a reversible post-translational modification functionally …
The Human Immunodeficiency Virus Type 2 Vpx Protein Usurps the CUL4A-DDB1DCAF1 Ubiquitin Ligase To Overcome a Postentry Block in Macrophage Infection
A Bergamaschi, D Ayinde, A David, E Le Rouzic… - Journal of …, 2009 - Am Soc Microbiol
The human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV)
genomes encode several auxiliary proteins that have increasingly shown their importance in …
genomes encode several auxiliary proteins that have increasingly shown their importance in …
CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels
AB Gonçalves, SK Hasselbalch, BB Joensen, S Patzke… - Elife, 2021 - elifesciences.org
CEP78 is a centrosomal protein implicated in ciliogenesis and ciliary length control, and
mutations in the CEP78 gene cause retinal cone-rod dystrophy associated with hearing loss …
mutations in the CEP78 gene cause retinal cone-rod dystrophy associated with hearing loss …
HIV-1 Vpr: mechanisms of G2 arrest and apoptosis
JL Andersen, E Le Rouzic, V Planelles - Experimental and molecular …, 2008 - Elsevier
Since the first isolation of HIV-1 from a patient with generalized lymphadenopathy in 1983,
great progress has been made in understanding the viral life cycle and the functional …
great progress has been made in understanding the viral life cycle and the functional …
[HTML][HTML] The HIV-1 Vpr protein: a multifaceted target for therapeutic intervention
ME González - International journal of molecular sciences, 2017 - mdpi.com
The human immunodeficiency virus type 1 (HIV-1) Vpr protein is an attractive target for
antiretroviral drug development. The conservation both of the structure along virus evolution …
antiretroviral drug development. The conservation both of the structure along virus evolution …
Caspase cleavage of gasdermin E causes neuronal pyroptosis in HIV-associated neurocognitive disorder
Abstract Despite effective antiretroviral therapies, 20–30% of persons with treated HIV
infection develop a neurodegenerative syndrome termed HIV-associated neurocognitive …
infection develop a neurodegenerative syndrome termed HIV-associated neurocognitive …